Arkolith/Insider Trading/AQST/Form 4

Cioffi Melina

SVP, Regulatory AffairsAquestive Therapeutics, Inc. (AQST) · full profile →Form 4 · filed Mar 11, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$106K
Net Open-Market Flow
-$106K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 10, 2026Sell(S)25K$4.17$106K275K
Mar 9, 2026Grant(A)100K—$0300K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 9, 2026Grant(A)75K$4.29$322K75K

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001214659-26-003144) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML